Vir Biotechnology reports early progress in antibody treatment for Covid-19
NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES, NIH
The company, which is working with the Cambridge, Mass., biotech firm Biogen, said that human tests of the drugs could begin in three to five months.
.png)
No hay comentarios:
Publicar un comentario